CHERRY FLAVOUR PEPTO-BISMOL TAB 262 MG — DIN 01983725
BISMUTH SUBSALICYLATE : 262 MG CALCIUM CARBONATE : 350 MG · PROCTER & GAMBLE INC · TABLET · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is CHERRY FLAVOUR PEPTO-BISMOL TAB?
CHERRY FLAVOUR PEPTO-BISMOL TAB 262 MG contains BISMUTH SUBSALICYLATE : 262 MG CALCIUM CARBONATE : 350 MG. It is listed in the Health Canada Drug Product Database under DIN 01983725, held by PROCTER & GAMBLE INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 31-Oct-1997. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Antacids, Other Combinations in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
10 holders have a Canadian DIN containing Antacids, Other Combinations, across 14 DINs, of which 2 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| PROCTER & GAMBLE INC | 3 | 1 | CHERRY FLAVOUR PEPTO-BISMOL TAB, PEPTO-BISMOL CHEWABLES, PEPTO-BISMOL TABLETS | Sourceable in Canada |
| GUARDIAN DRUG COMPANY INC | 2 | 1 | STOMACH RELIEF CHEWABLE FLAVOURED TABLETS, STOMACH RELIEF CHEWABLE TABLETS | Sourceable in Canada |
| PERRIGO INTERNATIONAL | 2 | 0 | BISMUTH + ANTACID (CHEWABLE TABLETS), PINK BISMUTH PLUS ANTACID RELIEF TABLETS | No marketed DIN |
| ADVERTISING UNLIMITED INC. (A.U.I.) | 1 | 0 | ANTACID 2 TABLETS | No marketed DIN |
| AURIUM PHARMA INC. | 1 | 0 | MUCAINE - SUS | No marketed DIN |
| CELLCHEM PHARMACEUTICALS INC. | 1 | 0 | CHEWABLE BISMUTH TABLETS WITH CALCIUM CARBONATE | No marketed DIN |
| RICHARDSON-VICKS, DIVISION OF THE PROCTER & GAMBLE COMPANY | 1 | 0 | PEPTO-BISMOL TAB | No marketed DIN |
| TANTA PHARMACEUTICALS INC | 1 | 0 | BISMUTH TABLETS WITH CALCIUM CARBONATE | No marketed DIN |
| TECHNILAB PHARMA INC. | 1 | 0 | BISMED CHEWABLE TABLETS | No marketed DIN |
| VITA HEALTH PRODUCTS INC | 1 | 0 | BISMUTH CHEWABLE TABLETS | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 262 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Antacids, Other Combinations |
|---|---|
| ATC code | A02AX |
| AHFS class | 56:04.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 01983725 |
|---|---|
| DIN (unpadded, as printed on some documents) | 1983725 |
| Brand name | CHERRY FLAVOUR PEPTO-BISMOL TAB |
| Generic / active ingredient | BISMUTH SUBSALICYLATE : 262 MG CALCIUM CARBONATE : 350 MG |
| Market authorization holder | PROCTER & GAMBLE INC |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A02AX |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A02AX |
| Current status | CANCELLED POST MARKET |
| Status date | 31-Oct-1997 |
| Original market date | 1992-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
2 of 14 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| PEPTO-BISMOL CHEWABLES | 350 MG | TABLET (CHEWABLE) | PROCTER & GAMBLE INC | MARKETED | 02237315 |
| STOMACH RELIEF CHEWABLE TABLETS | 262 MG | TABLET (CHEWABLE) | GUARDIAN DRUG COMPANY INC | MARKETED | 02389215 |
| ANTACID 2 TABLETS | 61 MG | TABLET | ADVERTISING UNLIMITED INC. (A.U.I.) | CANCELLED POST MARKET | 01904310 |
| BISMED CHEWABLE TABLETS | 350 MG | TABLET | TECHNILAB PHARMA INC. | CANCELLED POST MARKET | 00810509 |
| BISMUTH + ANTACID (CHEWABLE TABLETS) | 262 MG | TABLET (CHEWABLE) | PERRIGO INTERNATIONAL | CANCELLED POST MARKET | 02240473 |
| BISMUTH CHEWABLE TABLETS | 308 MG | TABLET | VITA HEALTH PRODUCTS INC | CANCELLED POST MARKET | 02243124 |
| BISMUTH TABLETS WITH CALCIUM CARBONATE | 350 MG | TABLET (CHEWABLE) | TANTA PHARMACEUTICALS INC | APPROVED | 02317117 |
| CHEWABLE BISMUTH TABLETS WITH CALCIUM CARBONATE | 262 MG | TABLET (CHEWABLE) | CELLCHEM PHARMACEUTICALS INC. | DORMANT | 02319888 |
| MUCAINE - SUS | 100 MG / 5 ML | SUSPENSION | AURIUM PHARMA INC. | CANCELLED POST MARKET | 02125013 |
| PEPTO-BISMOL TAB | 262 MG | TABLET | RICHARDSON-VICKS, DIVISION OF THE PROCTER & GAMBLE COMPANY | CANCELLED POST MARKET | 00879037 |
2 · Same class — other molecules in ATC A02AX
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Antacids, Other Combinations | ANTACID 2 TABLETS · BISMED CHEWABLE TABLETS · BISMUTH + ANTACID (CHEWABLE TABLETS) · BISMUTH CHEWABLE TABLETS · +10 more | 14 | 2 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC A02A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| A02AF | Magaldrate And Antiflatulents · Ordinary Salt Combinations And Antiflatulents | 59 | 4 |
| A02AA | Magnesium Carbonate · Magnesium Hydroxide | 14 | 0 |
| A02AB | Aluminium Hydroxide | 1 | 0 |
| A02AC | Calcium Carbonate | 16 | 0 |
| A02AD | Magaldrate · Ordinary Salt Combinations | 47 | 0 |
| A02AH | Antacids With Sodium Bicarbonate | 9 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.